Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials

American Journal of Gastroenterology

Volumn 93, Issue 9, 1998, Pages 1409-1415

  Laine, Loren ^a   Hopkins, Robert J ^b   Girardi, Luigi S ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; RANITIDINE;

ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DUODENUM ULCER; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; META ANALYSIS; MULTICENTER STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT OUTCOME;

DOUBLE-BLIND METHOD; DUODENAL ULCER; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS; RECURRENCE;

EID: 0032172997     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(98)00333-5     Document Type: Article

References (29)

1. 1. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
2. 2. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Helicobacter pylori. In: Schistosomes, liver flukes, and Helicobacter pylori: Views and expert opinions of an IARC Working Group on the evaluation of carcinogenic risks to humans. Lyon: IARC, 1994:177-240.
3. 3. Roggero E, Zucca E, Pinotti G, et al. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 1995;122:767-9.
4. 4. Van Deventer GM, Elashoff JD, Reedy TJ, et al. A randomized study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer. N Engl J Med 1989;320:1113-9.
5. 5. Hopkins RJ, Girardi LS, Turney EA. Relationships between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: A review. Gastroenterology 1996;110:1244-52.
6. 6. Penston JG. Review article: Clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease. Aliment Pharmacol Ther 1996;10:469-86.
7. 7. Soll AH, Isenberg JI. Duodenal ulcer disease. In: Sleisenger MH, Fordtran JS, ed. Gastrointestinal disease. Volume 1. 3rd ed. Philadelphia: W. B. Saunders, 1983:625-72.
8. 8. Laine L, Stein C, Neil G. Limited efficacy of omeprazole-based dual and triple therapy for Helicobacter pylori: A randomized trial employing "optimal" dosing. Am J Gastroenterol 1995;90:1407-10.
9. 9. Graham KS, Malaty H, el-Zimaity HM, et al. Variability with omeprazole-amoxicillin combination for treatment of Helicobacter pylori infection. Am J Gastroenterol 1995;90:1415-8.
10. 10. Labenz J, Ruhl GH, Bertrams J, et al. Medium- and high-dose omeprazole plus amoxicillin for eradication of Helicobacter pylori in duodenal ulcer disease. Dig Dis Sci 1994;39:1483-7.
11. 11. Bayerdorffer E, Mannes GA, Sommer A, et al. High dose omeprazole treatment combined with amoxicillin eradicates Helicobacter pylori. Eur J Gastroenterol Hepatol 1992;4:697-702.
12. 12. Study M93-067. Abbott Laboratories, Abbott Park, IL; data on file.
13. 13. Hunt R, Schartz H, Fitch D, et al. Dual therapy of clarithromycin (CL) and omeprazole (OM) for treatment of patients with duodenal ulcers (DU) associated with H. pylori (HP) infection. Gastroenterology 1995; 108:A116 (abstract).
14. 14. Peterson WL, Ciociola AA, Sykes DL, et al. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. Aliment Pharmacol Ther 1996;10:251-6.
15. 15. Lanza F, Ciociola AA, Sykes D, et al. Ranitidine bismuth citrate plus clarithromycin is effective in eradicating H pylori, healing duodenal ulcers, and preventing ulcer relapse. Gastroenterology 1996;110:A172 (abstract).
16. 16. Graham DY, Hirschowitz B, Ciociola AA, et al. Ranitidine bismuth citrate plus amoxicillin for the treatment of duodenal ulcer disease. Am J Gastroenterol 1995;90:1634 (abstract).
17. 17. Study 029. Astra Merck, Inc., Wayne, PA; data on file.
18. 18. Unge P, Gad A, Eriksson K, et al. Amoxicillin added to omeprazole prevents relapse in the treatment of duodenal ulcer patients. Eur J Gastroenterol Hepatol 1993;5:325-31.
19. 19. Bayerdorffer E, Miehlke S, Mannes GA, et al. Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterology 1995;108:1412.
20. 20. Logan RPH, Bardhan KD, Celestin LR, et al. Eradication of Helicobacter pylori and prevention of recurrence of duodenal ulcer: A randomized, double-blind, multi-centre trial of omeprazole with or without clarithromycin. Aliment Pharmacol Ther 1995;9:417-23.
21. 21. O'Morain C, Dettmer A, Rambow A, et al. Double-blind, multicenter, placebo-controlled evaluation of clarithromycin and omeprazole for Helicobacter pylori-associated duodenal ulcer. Helicobacter 1996;1: 130-7.
22. 22. Hentschell E, Brandstatter G, Dragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993;328: 308-12.
23. 23. Lanas AI, Remacha B, Esteva F, et al. Risk factors associated with refractory peptic ulcers. Gastroenterology 1995;109:1124-33.
24. 24. Bardhan KD, Graham DY, Hunt RH, et al. Effects of smoking on cure of Helicobacter pylori infection and duodenal ulcer recurrence in patients treated with clarithromycin and omeprazole. Helicobacter 1997;2:27-31.
25. 25. McGowan CC, Cover TL, Blaser MJ. Helicobacter pylori and gastric acid: Biological and therapeutic implications. Gastroenterology 1996; 110:926-38.
26. 26. El-Omar EM, Penman ID, Ardill JES, et al. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995:109:681-91.
27. 27. McColl KEL, El-Nujumi AM, Chittajallu RS, et al. A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration. Gut 1993;34:762-8.
28. 28. Kurata JH, Nogawa AN. Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol 1997;24:2-17.
29. 29. Parsonnet J, Blaser MJ, Perez-Perez GI, et al. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology 1992;102:41-6.